Research Faculty Member | Research Interests |
| Anthony J. Alberg, Ph.D. | Biostatistics/bioinformatics and epidemiology |
| Matt Carpenter | |
| Betsy Davis | Masticatory function in oral cancer;
Mandibular movement analysis in oral cancer survivors |
| Saeed Elojeimy | FasL gene therapy: a new therapeutic modality for head and neck
cancer; Specific Aim 1: We will seek to define the role of AC in tumorigenesis and progression observed in our HNSCC models; Specific Aim 2: We will determine if AC is a biomarker in an aggressive subset of HNSCC. |
| Marion Boyd Gillespie, MD | Blocking the Progression of HPV Related Viral Carcinogenesis |
| James Hebert, MSPH, ScD | Cancer epidemiology |
| Betsy Hille | |
| Keith Kirkwood | Inflammation in the HN tumor microenvironment as it relates to tumor progression |
| Eric Lentch | Cost analysis for minimally invasive thyroidectomy; Meta-Analysis of photodynamic therapy for head and neck cancer |
| Bonnie Martin-Harris, PhD, CCC-SLP, BRS-S | Standardized assessment of speech and swallowing disorders in patients treated for head and neck cancer and relationship to health and quality of life outcomes; therapeutic interventions for improved speech, voice and swallowing function |
| Peter Miller, Ph.D. | |
James Morris
| FasL gene therapy: a new therapeutic modality for head and neck
cancer; Specific Aim 1: We will seek to define the role of AC in tumorigenesis and progression observed in our HNSCC models; Specific Aim 2: We will determine if AC is a biomarker in an aggressive subset of HNSCC. |
| Jennifer Mulligan | |
Shaun Nguyen, M.D.
| |
| James Norris, PhD | Development of anti-tumor therapies |
| Besim Ogretmen, PhD | Regulation of tumor growth |
| Christopher H. Parsons, M.D. | |
| Mary Richardson | Ongoing study relating to T1-T2 tongue primary SCC looking at prognostic parameters via histopathology and molecular markers within various subsets |
| Steven Rosenzweig Ph.D. | Receptor crosstalk in HNSCC metastatic progression; VEGF-induced invadopodia formation is HEF1 dependent |
| Semyon Rubinchek | |
| Tihana Rumboldt | N3B (extracapsular extension) project with Drs. Richardson, Spampinato and Rumboldt |
| Zoran Rumboldt | CT perfusion of head and neck cancer - predictive value, treated neck; CT for nodal disease after (chemo) radiation; Extracapsular spread of nodal disease - imaging evaluation and prognostic value
- PET-CT for H&N cancer (a number of subtopics) |
Katherine Sterba
| |
| Natalie Sutkowski, Ph.D. | Microbiology and immunotherapy |
| Xuejun Wen | Adult stem cells from craniofacial region for tissue reconstruction after head and neck cancer removal currently under investigation in Wen lab are: synovial membrane stem cells from TMJ and dental pulp stem cells; Computer aided implant design and fabrication for the re-construction of craniofacial tissue after tumor removal; Developing butyric acid based anti-tumor biomaterials for the re-construction of craniofacial tissue after tumor removal
|
| Rita Young, PhD | Immunotherapy with premalignant oral lesions to prevent oral cancer; Contributions of macrophages to the progression of oral premalignant lesions to cancer; Vitamin D treatment to drive differentiation of immune inhibitory progenitor cells to mature cells that stimulate immune reactivity against oral cancer; Tumor-associated NK cells recruit cells that inhibit immune reactivity against cancer. |
Hon Yuen, PhD | Toxicity associated with tumor treatments |
